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Abstract
Stroke is the second most common cause of death globally and an important cause of disability in adults. According 
to the GEDA 2014/2015-EHIS study, 1.6% of adults (1.7% of women and 1.5% of men) in Germany had a stroke or 
chronic consequences of stroke during the past 12 months. For those aged under 55 years, the 12-month prevalence 
of these health problems remains well below 1% for both sexes, but then increases steeply and disproportionately 
to 6.3% for those aged 75 years and over. Prevalence among women with a low level of education (3.6%) is higher 
than among women with a high level of education (0.6%). Education has only a weak effect on prevalence among 
men. The indicator analysed here (12-month prevalence of stroke or chronic consequences of stroke) was developed 
for the European Health Interview Survey (EHIS) 2014/2015, which means that comparative data for Germany is 
not yet available.
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Introduction
Stroke is a disease of the brain characterised by sudden 
damage to brain tissue following either blockage of blood 
vessels (ischemic stroke) or bleeding (haemorrhagic 
stroke) in the brain [1, 2]. About 80-85% of strokes are 
ischemic strokes resulting from an acute blockage of a 
brain artery by a blood clot. Ischemic strokes are caused 
mostly by atherosclerosis of the carotid or cerebral arter-
ies or blood clots from the heart caused by atrial fibril-
lation or heart valve diseases [1, 3, 4]. Haemorrhagic 
strokes in contrast typically occur due to ruptures of 
small arteries deep in the brain weakened by the long-
term effects of high blood pressure. Insufficient blood 
supply or bleeding in the brain cause localised or gen-
eralized dysfunction to the brain, resulting in sudden 
neurologic symptoms. The most frequent symptoms are 
paresis (weakness) or paralysis and impaired sensation 
(numbness) of arm, leg or face (mostly limited to one 
side of the body), speech problems, loss of vision, dizzi-
ness, unconsciousness and severe headache.
Stroke is the second most common cause of death in 
Germany and globally [2, 5, 6] and one of the most fre-
quent causes of disability in adults [2, 6, 7]. One third to 
one quarter of all stroke patients die within the first year 
after a stroke [1, 8, 9]. Up to 40% of those who survive 
will suffer longer-term impairments in daily activities. They 
may find it hard to move, wash or dress on their own or 
to eat [1, 2, 10-12]. In many cases, this means they will 
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require nursing care. An analysis of claims data from stat-
utory health insurance providers in Germany showed that 
the percentage of people who receive professional care 
increases by 13% to 19% after a stroke [13, 14]. 
In high-income countries, stroke mortality rates as 
well as the rate of new cases (incidence rate) have 
dropped continuously for many years [1, 2]. Demographic 
changes and the ageing of populations, however, have 
led to an increase in the absolute number of stroke 
patients in the population and this figure will probably 
continue to rise [1, 2]. 
Planning prevention and care will require information 
on the disease burden of stroke for the population. This 
has led to the introduction of an indicator for European 
health monitoring to measure the frequency and impact 
of stroke over time in European Union (EU) countries 
[15]. In the context of the European Health Interview Sur-
vey (EHIS) 2014/2015, the Robert Koch Institute’s study 
German Health Update (GEDA) 2014/2015 for the first 
time collected data on this indicator in Germany [16]. A 
Focus article in this edition describes European health 
monitoring and health indicators in more detail [17].
Methods
GEDA 2014/2015-EHIS surveyed various diseases and 
health problems. ‘During the past 12 months, have you 
had any of the following diseases or conditions?’ the 
survey asked, followed by a list of diseases. Participants 
were also asked whether they had suffered a ‘stroke’ or 
‘chronic consequences of stroke’ during the past 12 
months. Participants could fill out the GEDA 2014/2015-
EHIS questionnaire in writing or online. 
The indicator from European health monitoring used 
for this analysis is defined as presence of a stroke or 
chronic consequences of stroke during the past twelve 
months [15]. 
The analyses are based on data from 22,599 partici-
pants aged at least 18 years with valid answers on the 
12-month prevalence of stroke or chronic consequences
of stroke, excluding 1,417 participants (5.9% of the entire
sample) with missing data on these variables. Analyses
were carried out using a weighting factor that corrected
for deviations in the sample concerning gender, age, type
of community and education deviations the population
structure (as of 31 December 2014). The International
Standard Classification of Education (ISCED) was used
to make participant’s answers on education comparable
[18]. A detailed description of the methodology used by
GEDA 2014/2015-EHIS can be found in the article ‘Ger-
man Health Update – new data for Germany and Europe’
[16] in this issue.
Results and discussion
Overall, 1.7% of women and 1.5% of men aged over 18 
years reported having had a stroke or chronic conse-
quences of stroke during the past 12 months. The 
12-month prevalence of stroke or chronic conse quences
of stroke is below 1% for people aged under 55 years.
Prevalence then increases disproportionately to 6.4%
for women and 6.1% for men in those aged 75 years
and over. Women with a low level of education report-
ed stroke or chronic consequences of stroke during
the past 12 months considerably more often (3.6%)
than those with high level of education (1.3%). For men,
GEDA 2014/2015-EHIS
Data holder: Robert Koch Institute
Aims:  to provide reliable informa-
tion about the population’s 
health status, health-related 
behaviour and health care in 
Germany, with the possibility 
of a European comparison
Method:   questionnaires completed 
on paper or online
Population:   people aged 18 years and 
above with permanent resi-
dency in Germany
Sampling:   registry office sample; ran-
domly selected individuals 
from 301 communities in 
Germany were invited to par-
ticipate
Participants:   24,016 people (10,872 men; 
13,144 women)
Response rate:  26.9%
Study period:  November 2014 – July 2015
Data protection:  all participants were informed 
about the study’s aims and 
content and about data pro-
tection, and provided their 
informed consent
More information is available at 
www.geda-studie.de
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this correlation between stroke and education is far 
weaker.
The indicator for the 12-month prevalence of stroke 
or chronic consequences of stroke presented here is 
taken from European health monitoring and was first 
surveyed for Germany in GEDA 2014/2015-EHIS. The 
results confirm the well-known existence of a relation 
between stroke and older age and lower socio-economic 
status [2, 19]. In line with data on the lifetime prevalence 
of stroke, no relevant differences between genders were-
found [2]. In a European comparison, variability between 
EU countries in the 12-month prevalence of stroke or 
chronic consequences of stroke was very low [17].
Due to methodological differences, prevalence as 
reported by the new EHIS indicator cannot be directly 
compared to other epidemiologic data. Firstly, the indi-
cator for the first time combines stroke and chronic con-
sequences of stroke. By including chronic consequences, 
the subjective perception of participants, which in turn 
is probably influenced by factors such as education and 
gender, has a greater weight in the mixed indicator. Sec-
ondly, unlike in most other international health surveys, 
the new EHIS indicators did not ask explicitly for physi-
cian-diagnosed diseases [20-22].
Instead of using the 12-month prevalence reported in 
the EHIS survey, epidemiologic surveys and health 
reporting generally report and base their comparisons 
on the lifetime prevalence of physician-diagnosed stroke 
[2, 22, 23]. For Germany, the GEDA 2009/2012 study 
estimated a lifetime prevalence of 2.4% for women and 
2.6% for men [2]. Prevalence in Germany seems not to 
have changed much during the past twelve years and 
there are apparently no significant differences to other 
countries [2, 20].
Considered separately, the indicator ‘chronic conse-
quences of stroke’ in GEDA 2014/2015-EHIS evidences 
Women % (95%-CI)
Women total 1.7 (1.4-2.0)
Age
18 – 44 years 0.3 (0.1-0.6)
45 – 54 years 0.5 (0.2-1.0)
55 – 64 years 1.3 (0.8-2.0)
65 – 74 years 3.4 (2.5-4.7)





Total (women and men) 1.6 (1.4-1.8)
CI=Confidence interval
Men % (95%-CI)
Men total 1.5 (1.3-1.8)
Age
18 – 44 years 0.1 (0.0-0.4)
45 – 54 years 0.9 (0.5-1.5)
55 – 64 years 1.6 (1.1-2.5)
65 – 74 years 3.8 (2.8-5.2)





Total (women and men) 1.6 (1.4-1.8)
Table 1 
12-month prevalence of stroke or chronic
consequences of stroke according to gender, 
age and level of education (n=22,599)
Source: GEDA 2014/2015-EHIS
1.7% of women and 1.5% of 
men report having had a 
stroke or chronic conse-
quences of stroke during the 
past 12 months.
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a 12-month prevalence for women and men of 1.1% (data 
not shown). Taken on its own, this prevalence seems 
plausible, assuming that 40% of stroke patients suffer 
from chronic disabilities [1, 2] and a lifetime prevalence 
of 2.5% [2, 20]. As described above, the validity of infor-
mation regarding self-perceived chronic consequences 
of stroke is difficult to evaluate.
The EHIS questionnaire resulted from a long process 
of consultation between the 28 EU member countries. 
The questions on chronic diseases, it was decided, would 
not ask for physician-diagnosed diseases, but for self-per-
ceived diseases and so differed from conventional stud-
ies. For heart attack and stroke, it was additionally decided 
to include chronic consequences of the diseases. These 
decisions were based on the assumption that this would 
increase the survey’s relevance for public health and 
reduce the impact of regional differences in care supply 
[15-17, 24]. Furthermore, gathering data on 12-month prev-
alence aimed to shed a light on the current burden of 
these diseases and reduce recall bias in data collection 
[15-17, 24]. The methodological difficulties described above 
and lacking comparability with other sources of data, how-
ever, make it seem unlikely that EHIS indicators for stroke 
as well as the indicators for heart attack and coronary 
heart diseases (compare Fact sheet on CHD in this issue 
[24]) will be used in other surveys beyond EHIS. 
In spite of their described limitations, the new EHIS 
indicators have their value for harmonised, indicator-based 
health monitoring in the EU that can help identify regional 
differences, positive and negative trends, as well as the 
potentials for prevention in European populations and 
reveal health policy fields that require further action.
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